H K Manji1, G J Moore, G Chen. 1. Laboratory of Molecular Pathophysiology, Wayne State University School of Medicine, Detroit, Michigan, USA. manjih@intra.nimh.nih.gov
Abstract
BACKGROUND: New research is dramatically altering our understanding of the molecular mechanisms underlying neuronal communication. AIM: To elucidate the molecular mechanisms underlying the therapeutic effects of mood stabilizers. METHOD: Results from integrated clinical and laboratory studies are reviewed. RESULTS: Chronic administration of lithium and valproate produced a striking reduction in protein kinase C (PKC) isozymes in rat frontal cortex and hippocampus. In a small study, tamoxifen (also a PKC inhibitor) had marked antimanic efficacy. Both lithium and valproate regulate the DNA binding activity of the activator protein I family of transcription factors. Using mRNA differential display, it was also shown that chronic administration of lithium and valproate modulates expression of several genes. An exciting finding is that of a robust elevation in the levels of the cytoprotective protein, bcl-2. CONCLUSIONS: The results suggest that regulation of signalling pathways may play a major part in the long-term actions of mood stabilizers. Additionally, mood stabilizers may exert underappreciated neuroprotective effects.
BACKGROUND: New research is dramatically altering our understanding of the molecular mechanisms underlying neuronal communication. AIM: To elucidate the molecular mechanisms underlying the therapeutic effects of mood stabilizers. METHOD: Results from integrated clinical and laboratory studies are reviewed. RESULTS: Chronic administration of lithium and valproate produced a striking reduction in protein kinase C (PKC) isozymes in rat frontal cortex and hippocampus. In a small study, tamoxifen (also a PKC inhibitor) had marked antimanic efficacy. Both lithium and valproate regulate the DNA binding activity of the activator protein I family of transcription factors. Using mRNA differential display, it was also shown that chronic administration of lithium and valproate modulates expression of several genes. An exciting finding is that of a robust elevation in the levels of the cytoprotective protein, bcl-2. CONCLUSIONS: The results suggest that regulation of signalling pathways may play a major part in the long-term actions of mood stabilizers. Additionally, mood stabilizers may exert underappreciated neuroprotective effects.
Authors: Jorge R C Almeida; Dalila Akkal; Stefanie Hassel; Michael J Travis; Layla Banihashemi; Natalie Kerr; David J Kupfer; Mary L Phillips Journal: Psychiatry Res Date: 2008-12-19 Impact factor: 3.222
Authors: Giacomo Salvadore; Wayne C Drevets; Ioline D Henter; Carlos A Zarate; Husseini K Manji Journal: Early Interv Psychiatry Date: 2008-08 Impact factor: 2.732
Authors: Mikhil N Bamne; Christine A Ponder; Joel A Wood; Hader Mansour; Ellen Frank; David J Kupfer; Michael W Young; Vishwajit L Nimgaonkar Journal: Bipolar Disord Date: 2013-06-20 Impact factor: 6.744
Authors: Du Lei; Wenbin Li; Maxwell J Tallman; L Rodrigo Patino; Robert K McNamara; Jeffrey R Strawn; Christina C Klein; Fabiano G Nery; David E Fleck; Kun Qin; Yuan Ai; Jing Yang; Wenjing Zhang; Su Lui; Qiyong Gong; Caleb M Adler; John A Sweeney; Melissa P DelBello Journal: Neuropsychopharmacology Date: 2021-03-22 Impact factor: 7.853
Authors: A Gupta; T G Schulze; V Nagarajan; N Akula; W Corona; X-y Jiang; N Hunter; F J McMahon; S D Detera-Wadleigh Journal: Pharmacogenomics J Date: 2011-03-08 Impact factor: 3.550
Authors: Roopali Yadav; Subhash C Gupta; Brandon G Hillman; Jay M Bhatt; Dustin J Stairs; Shashank M Dravid Journal: PLoS One Date: 2012-03-07 Impact factor: 3.240